Organismes de services de gestion : Questions médicales fréquentes
Nom anglais: Management Service Organizations
Descriptor UI:D021661
Tree Number:N04.452.758.372
Termes MeSH sélectionnés :
Drug Compounding
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Organismes de services de gestion : Questions médicales les plus fréquentes",
"headline": "Organismes de services de gestion : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Organismes de services de gestion : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-03",
"dateModified": "2025-02-28",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Organismes de services de gestion"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Pratique professionnelle",
"url": "https://questionsmedicales.fr/mesh/D011364",
"about": {
"@type": "MedicalCondition",
"name": "Pratique professionnelle",
"code": {
"@type": "MedicalCode",
"code": "D011364",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N04.452.758"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Organismes de services de gestion",
"alternateName": "Management Service Organizations",
"code": {
"@type": "MedicalCode",
"code": "D021661",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Aminu K Bello",
"url": "https://questionsmedicales.fr/author/Aminu%20K%20Bello",
"affiliation": {
"@type": "Organization",
"name": "Division of Nephrology and Immunology, Department of Medicine, University of Alberta Edmonton, Alberta, Canada."
}
},
{
"@type": "Person",
"name": "Vivekanand Jha",
"url": "https://questionsmedicales.fr/author/Vivekanand%20Jha",
"affiliation": {
"@type": "Organization",
"name": "George Institute for Global Health, University of New South Wales, New Delhi, India."
}
},
{
"@type": "Person",
"name": "Adeera Levin",
"url": "https://questionsmedicales.fr/author/Adeera%20Levin",
"affiliation": {
"@type": "Organization",
"name": "Nephrology Division, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada."
}
},
{
"@type": "Person",
"name": "Marcello Tonelli",
"url": "https://questionsmedicales.fr/author/Marcello%20Tonelli",
"affiliation": {
"@type": "Organization",
"name": "Department of Medicine, University of Calgary, Calgary, Alberta, Canada."
}
},
{
"@type": "Person",
"name": "Syed Saad",
"url": "https://questionsmedicales.fr/author/Syed%20Saad",
"affiliation": {
"@type": "Organization",
"name": "Department of Medicine, University of Alberta, Edmonton, Alberta, Canada."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Compounded medications for cardiovascular use in neonatology: an integrative review.",
"datePublished": "2022-09-09",
"url": "https://questionsmedicales.fr/article/36102396",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1590/1984-0462/2023/41/2021167"
}
},
{
"@type": "ScholarlyArticle",
"name": "Impact of Apparatus and Adapter on In vitro Drug Release of Ophthalmic Semisolid Drug Products.",
"datePublished": "2023-09-07",
"url": "https://questionsmedicales.fr/article/37679656",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11095-023-03586-x"
}
},
{
"@type": "ScholarlyArticle",
"name": "Economic Considerations and Cost-Saving Strategies for Nonsterile Compounding Education.",
"datePublished": "2023-07-16",
"url": "https://questionsmedicales.fr/article/37454811",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ajpe.2023.100571"
}
},
{
"@type": "ScholarlyArticle",
"name": "Advancing algorithmic drug product development: Recommendations for machine learning approaches in drug formulation.",
"datePublished": "2023-08-09",
"url": "https://questionsmedicales.fr/article/37562550",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ejps.2023.106562"
}
},
{
"@type": "ScholarlyArticle",
"name": "Accelerated Predictive Stability Study of a Pediatric Drug Product for a Supplemental New Drug Application.",
"datePublished": "2024-06-06",
"url": "https://questionsmedicales.fr/article/38844721",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1208/s12249-024-02848-0"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Administration des services de santé",
"item": "https://questionsmedicales.fr/mesh/D006298"
},
{
"@type": "ListItem",
"position": 3,
"name": "Organisation et administration",
"item": "https://questionsmedicales.fr/mesh/D009934"
},
{
"@type": "ListItem",
"position": 4,
"name": "Pratique professionnelle",
"item": "https://questionsmedicales.fr/mesh/D011364"
},
{
"@type": "ListItem",
"position": 5,
"name": "Organismes de services de gestion",
"item": "https://questionsmedicales.fr/mesh/D021661"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Organismes de services de gestion - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Organismes de services de gestion",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-12",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Organismes de services de gestion",
"description": "Comment identifier un OSG ?\nQuels services offrent les OSG ?\nQuels sont les types d'OSG ?\nComment évaluer l'efficacité d'un OSG ?\nQuels outils utilisent les OSG ?",
"url": "https://questionsmedicales.fr/mesh/D021661?mesh_terms=Drug+Compounding&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Organismes de services de gestion",
"description": "Quels signes indiquent un besoin d'OSG ?\nComment reconnaître une mauvaise gestion ?\nQuels impacts d'une mauvaise gestion ?\nQuels symptômes d'une surcharge administrative ?\nComment détecter des erreurs fréquentes ?",
"url": "https://questionsmedicales.fr/mesh/D021661?mesh_terms=Drug+Compounding&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Organismes de services de gestion",
"description": "Comment prévenir les erreurs de gestion ?\nQuelles pratiques recommandées pour les OSG ?\nComment assurer la conformité réglementaire ?\nQuels outils pour la prévention des risques ?\nComment sensibiliser le personnel aux OSG ?",
"url": "https://questionsmedicales.fr/mesh/D021661?mesh_terms=Drug+Compounding&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Organismes de services de gestion",
"description": "Comment un OSG améliore-t-il la gestion ?\nQuels outils de gestion sont recommandés ?\nComment former le personnel à l'OSG ?\nQuels sont les bénéfices d'un OSG ?\nComment évaluer un OSG ?",
"url": "https://questionsmedicales.fr/mesh/D021661?mesh_terms=Drug+Compounding&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Organismes de services de gestion",
"description": "Quelles complications d'une mauvaise gestion ?\nComment une mauvaise gestion affecte-t-elle les soins ?\nQuels risques d'une surcharge administrative ?\nComment gérer les plaintes des patients ?\nQuelles conséquences d'une non-conformité ?",
"url": "https://questionsmedicales.fr/mesh/D021661?mesh_terms=Drug+Compounding&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Organismes de services de gestion",
"description": "Quels facteurs augmentent le besoin d'OSG ?\nComment la technologie influence-t-elle les OSG ?\nQuels sont les risques liés à la gestion interne ?\nComment le marché affecte-t-il les OSG ?\nQuels impacts des changements réglementaires ?",
"url": "https://questionsmedicales.fr/mesh/D021661?mesh_terms=Drug+Compounding&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment identifier un OSG ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un OSG est identifié par ses services de gestion administrative et de soutien aux pratiques médicales."
}
},
{
"@type": "Question",
"name": "Quels services offrent les OSG ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les OSG offrent des services tels que la facturation, la gestion des ressources humaines et le soutien technologique."
}
},
{
"@type": "Question",
"name": "Quels sont les types d'OSG ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les types d'OSG incluent ceux spécialisés en facturation, en gestion de la qualité et en conformité réglementaire."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'efficacité d'un OSG ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité d'un OSG peut être évaluée par des indicateurs de performance tels que la satisfaction des clients et la réduction des coûts."
}
},
{
"@type": "Question",
"name": "Quels outils utilisent les OSG ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les OSG utilisent des logiciels de gestion, des systèmes de facturation et des plateformes de communication."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent un besoin d'OSG ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes incluent une surcharge administrative, des erreurs fréquentes et une mauvaise gestion du temps."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une mauvaise gestion ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une mauvaise gestion se manifeste par des retards dans les paiements, des plaintes de patients et des audits défavorables."
}
},
{
"@type": "Question",
"name": "Quels impacts d'une mauvaise gestion ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les impacts incluent une baisse de la qualité des soins, une insatisfaction des patients et des pertes financières."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une surcharge administrative ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent le stress du personnel, des délais prolongés et une communication inefficace."
}
},
{
"@type": "Question",
"name": "Comment détecter des erreurs fréquentes ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des audits réguliers et des retours d'expérience des employés aident à détecter les erreurs fréquentes."
}
},
{
"@type": "Question",
"name": "Comment prévenir les erreurs de gestion ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par des formations régulières, des audits et l'utilisation de technologies adaptées."
}
},
{
"@type": "Question",
"name": "Quelles pratiques recommandées pour les OSG ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les pratiques recommandées incluent la standardisation des processus et la mise en place de contrôles internes."
}
},
{
"@type": "Question",
"name": "Comment assurer la conformité réglementaire ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Assurer la conformité nécessite des audits réguliers et une mise à jour continue des connaissances réglementaires."
}
},
{
"@type": "Question",
"name": "Quels outils pour la prévention des risques ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des outils comme les logiciels de gestion des risques et les plateformes de communication sont utiles."
}
},
{
"@type": "Question",
"name": "Comment sensibiliser le personnel aux OSG ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "La sensibilisation peut se faire par des formations, des réunions d'équipe et des bulletins d'information."
}
},
{
"@type": "Question",
"name": "Comment un OSG améliore-t-il la gestion ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un OSG améliore la gestion en optimisant les processus, réduisant les coûts et augmentant l'efficacité."
}
},
{
"@type": "Question",
"name": "Quels outils de gestion sont recommandés ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des outils comme les logiciels de gestion de cabinet et les systèmes de facturation sont recommandés."
}
},
{
"@type": "Question",
"name": "Comment former le personnel à l'OSG ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La formation peut inclure des ateliers, des sessions de coaching et des modules en ligne sur les outils de gestion."
}
},
{
"@type": "Question",
"name": "Quels sont les bénéfices d'un OSG ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les bénéfices incluent une meilleure gestion des ressources, une réduction des coûts et une satisfaction accrue des patients."
}
},
{
"@type": "Question",
"name": "Comment évaluer un OSG ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'évaluation se fait par des indicateurs de performance, des retours d'expérience et des audits réguliers."
}
},
{
"@type": "Question",
"name": "Quelles complications d'une mauvaise gestion ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des pertes financières, des plaintes de patients et des sanctions réglementaires."
}
},
{
"@type": "Question",
"name": "Comment une mauvaise gestion affecte-t-elle les soins ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut entraîner des retards dans les soins, une qualité inférieure et une insatisfaction des patients."
}
},
{
"@type": "Question",
"name": "Quels risques d'une surcharge administrative ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les risques incluent le burnout du personnel, des erreurs de traitement et une communication défaillante."
}
},
{
"@type": "Question",
"name": "Comment gérer les plaintes des patients ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion des plaintes nécessite une écoute active, une réponse rapide et des actions correctives."
}
},
{
"@type": "Question",
"name": "Quelles conséquences d'une non-conformité ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les conséquences incluent des amendes, des pertes de licence et une réputation ternie."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le besoin d'OSG ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent la taille de la pratique, la complexité des opérations et les changements réglementaires."
}
},
{
"@type": "Question",
"name": "Comment la technologie influence-t-elle les OSG ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "La technologie influence les OSG en améliorant l'efficacité, la communication et la gestion des données."
}
},
{
"@type": "Question",
"name": "Quels sont les risques liés à la gestion interne ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les risques incluent le manque de formation, la résistance au changement et des processus obsolètes."
}
},
{
"@type": "Question",
"name": "Comment le marché affecte-t-il les OSG ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les fluctuations du marché peuvent influencer la demande de services et la rentabilité des OSG."
}
},
{
"@type": "Question",
"name": "Quels impacts des changements réglementaires ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les changements réglementaires peuvent nécessiter des ajustements rapides et des formations supplémentaires."
}
}
]
}
]
}
To analyze the profile of the compounded cardiovascular medicines prescribed in neonatology in Brazil....
An integrative bibliographic review was carried out, including studies published in the last 20 years. The used descriptors were: Intensive Care Neonatal, Off-Label Use, Pharmaceutical Preparations, i...
The profile of routine prescrption in the neonatal unit was evaluated. The main cardiovascular medications prescribed as compounding formulation were: Spironolactone, Captopril, Furosemide, Hydrochlor...
It was possible to analyze the profile of compounded cardiovascular medicines prescribed in neonatology in Brazil. The results showed the need for the development of medications suitable for the neona...
In vitro release testing (IVRT) is a widely used tool for evaluating the quality and performance of drug products. However, standardized sample adaptors or drug release apparatus setups for IVRT studi...
Dexamethasone (DEX), a steroidal ingredient commonly used in ophthalmic drug products, was selected as a model drug. Ointments were prepared by mixing DEX in white petrolatum using a high shear mixer....
The sample adaptor setups had a minimal impact on cumulative drug release amount per area or release rate while USP IV apparatus with agitated flow enhanced drug release rates. The USP apparatus I wit...
USP apparatuses and sample adaptors are critical considerations for IVRT. Two-sided semisolid adapter provides higher cumulative release, facilitating the discrimination between low drug content ophth...
To determine the economic considerations, including cost-saving strategies, associated with nonsterile compounding education for students in schools and colleges of pharmacy across the United States....
An electronic survey was sent to the American Association of Colleges of Pharmacy Pharmaceutics Section and Laboratory Instructor's Special Interest Group members. Quantitative and qualitative data we...
Of 555 surveys sent, 46 were completed. Reported annual compounding budgets ranged from $3000 to $96,000. Reported annual equipment maintenance costs ranged from $400 to $18,000. Fifty percent of resp...
Findings from this study may assist pharmacy administrators and course directors in evaluating the costs associated with nonsterile compounding education across the Academy and, more importantly, dete...
Artificial intelligence is a rapidly expanding area of research, with the disruptive potential to transform traditional approaches in the pharmaceutical industry, from drug discovery and development t...
In this paper, we report two Accelerated Stability Assessment Program (ASAP) studies for a pediatric drug product. Whereas the first study using a generic design failed to establish a predictive model...
Magistral compounding has always been an integral part of pharmacy practice. The increasing demand worldwide for personalized drug treatments might be accommodated by an increase in magistral compound...
To investigate how 3D printing can be integrated into the existing compounding system by taking regulatory, economic, and profession-oriented aspects into account....
Semi-structured interviews were conducted with relevant Dutch stakeholders representing various health institutions, such as health ministries and boards, professional bodies, and different types of p...
A total of 15 Dutch stakeholders were interviewed. It was found that the prevalence of compounding in community pharmacies in the Netherlands has decreased as a result of the practice shifting to spec...
In the Netherlands, specialized compounding pharmacies have largely taken over compounding activities. 3D printing could be introduced within this system; however, challenges regarding how to regulate...
The development of liposome-based drugs was severely limited due to inefficient loading strategies. Herein, we developed a click reaction-mediated loading procedure by designing an enzyme-sensitive ma...
Treatment of metastatic lymph nodes (LNs) is challenging due to their unique architecture and biophysical traits. Systemic chemotherapy fails to impede tumor progression in LNs due to poor drug uptake...
Automated compounding device (ACD) are increasingly used for parenteral nutrition (PN) bag production, and their acquisition must be sufficiently thought. The law requires the qualification of these A...
The objective of this study was to prepare poly(lactide-co-glycolide) (PLGA) microparticles loaded with nanosized drug by combining non-aqueous wet bead milling and microencapsulation. 200-300 nm dexa...